AU2001248336A1 - Controlled release oral solid forms containing mesalazine as active agent - Google Patents

Controlled release oral solid forms containing mesalazine as active agent

Info

Publication number
AU2001248336A1
AU2001248336A1 AU2001248336A AU4833601A AU2001248336A1 AU 2001248336 A1 AU2001248336 A1 AU 2001248336A1 AU 2001248336 A AU2001248336 A AU 2001248336A AU 4833601 A AU4833601 A AU 4833601A AU 2001248336 A1 AU2001248336 A1 AU 2001248336A1
Authority
AU
Australia
Prior art keywords
active agent
controlled release
solid forms
oral solid
release oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248336A
Inventor
Francesco Montano
Vittorino Ravelli
Romano Rivolta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmatec International SRL
Original Assignee
Pharmatec International SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmatec International SRL filed Critical Pharmatec International SRL
Publication of AU2001248336A1 publication Critical patent/AU2001248336A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
AU2001248336A 2000-03-07 2001-03-07 Controlled release oral solid forms containing mesalazine as active agent Abandoned AU2001248336A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000MI000440A IT1318376B1 (en) 2000-03-07 2000-03-07 ORAL SOLID FORMS WITH CONTROLLED RELEASE CONTAINING MESALAZINE AS AN ACTIVE PRINCIPLE.
ITMI200A000440 2000-03-07
PCT/EP2001/002539 WO2001066094A1 (en) 2000-03-07 2001-03-07 Controlled release oral solid forms containing mesalazine as active agent

Publications (1)

Publication Number Publication Date
AU2001248336A1 true AU2001248336A1 (en) 2001-09-17

Family

ID=11444340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248336A Abandoned AU2001248336A1 (en) 2000-03-07 2001-03-07 Controlled release oral solid forms containing mesalazine as active agent

Country Status (3)

Country Link
AU (1) AU2001248336A1 (en)
IT (1) IT1318376B1 (en)
WO (1) WO2001066094A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AR036797A1 (en) 2001-10-15 2004-10-06 Ferring Bv A METHOD TO PREPARE A PHARMACEUTICAL COMPOSITION THAT INCLUDES 5-AMINOSALICILIC ACID TO USE IN THE TREATMENT OF ULCEROSE COLITIS AND CROHN DISEASES
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
CA2514879C (en) 2003-01-03 2014-09-16 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
WO2004087113A1 (en) * 2003-04-04 2004-10-14 Ranbaxy Laboratories Limited Pharmaceutical compositions for colon specific delivery
JP2007523664A (en) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ Sachet for pharmaceutical composition
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
US11744803B2 (en) 2005-07-29 2023-09-05 Stichting Groningen Centre for Drug Rese PH-controlled pulsatile delivery system, methods for preparation and use thereof
ITMI20070022A1 (en) 2007-01-09 2008-07-10 I P S Internat Products & Services Srl FORMULATION OF SOLID-RELEASED CONTROLLED PRODUCTS FOR ORAL USE IN SINGLE-DOSE BAGS AND RELATED PREPARATION PROCEDURE
WO2010077908A1 (en) * 2008-12-17 2010-07-08 Altheus Therapeutics, Inc. Oral formulations
IT1395143B1 (en) * 2009-08-06 2012-09-05 Sofar Spa GRANULAR COMPOSITIONS WITH CONTROLLED RELEASE OF MESALAZINE AND PROCESS FOR THEIR ACHIEVEMENT.
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
SG11201600933QA (en) * 2013-08-06 2016-03-30 Tasly Pharmaceutical Group Co Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof
IT201800011120A1 (en) 2018-12-14 2020-06-14 Dpl Pharma S P A SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR THE ADMINISTRATION OF MESALAZINE OR ITS DERIVATIVES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8003805L (en) * 1980-05-21 1981-11-22 Haessle Ab A PHARMACEUTICAL PREPARATION WITH IMPROVED EMISSION PROPERTY
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
JPH072650A (en) * 1993-06-18 1995-01-06 Tanabe Seiyaku Co Ltd Release part control type preparation
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
DE19732903A1 (en) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet formulation for the treatment of the intestinal tract

Also Published As

Publication number Publication date
ITMI20000440A0 (en) 2000-03-07
ITMI20000440A1 (en) 2001-09-07
IT1318376B1 (en) 2003-08-25
WO2001066094A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2002229140A1 (en) Controlled release pharmaceutical composition
GB0025208D0 (en) Delayed release pharmaceutical formulations
AU5066101A (en) Modified release formulations containing a hypnotic agent
AU6089200A (en) Rapid immediate release oral dosage form
AU2277101A (en) Stable extended release oral dosage composition
AU2001286677A1 (en) Controlled release of substances
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU9701101A (en) Methylphenidate modified release formulations
AU2003213151A1 (en) Controlled release solid dosage carbamazepine formulations
AU2001248336A1 (en) Controlled release oral solid forms containing mesalazine as active agent
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2001287977A1 (en) Controlled release formulations for oral administration
EP1151667A3 (en) Plant-activating agent
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2001290239A1 (en) Medicinal composition
AU6386801A (en) System for the release of active ingredients
AU2001232948A1 (en) Controlled release of drugs
AU2001248772A1 (en) Sustained release drug compositions
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
AU2003214121A1 (en) A system for the controlled release of active ingredients
IL148908A0 (en) Oral controlled release formulations
AU2002226047A1 (en) Release agent composition
AU2001241187A1 (en) Sustained release oral preparations
AU2879801A (en) Effervescent compositions comprising nimesulide